This Combined Synopsis/Solicitation opportunity from Department Of Veterans Affairs was posted on January 20, 2022. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6505--NTX Blood & Blood Products

Closed

36C25722Q0221Federal

Submission Closed12/03/2021, 08:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991

New

Federal

Blood Component Procurement and Rapid DeliveryThis subcontract, titled Blood Component Procurement and Rapid Delivery, involves the procurement and delivery of various blood products and components to support emergency, inpatient, and outpatient care at Wright Patterson AFB. Managed by the Department of Defense under the FA8601 Aflcmc Pzio agency, the contract requires the provider to supply prime contractors with critical medical components, including the ability to facilitate rapid shipments when in-house inventory is depleted to ensure patient safety. The selected provider must maintain 24/7 operational capability and hold CMMC Level 1 certification to meet security and availability standards. All blood components are to be delivered FOB Destination. The opportunity was posted on October 23, 2026, with a response deadline of October 29, 2026, falling under NAICS code 621991.

POSTED

DEADLINE

BPA - Blood Transfusion Services

Solicitation # FA860127Q0015

Solicitation FA8601-27-Q-0015 is a combined synopsis and request for quotation for a Blanket Purchase Agreement to provide blood components and reference laboratory transfusion testing services for Wright Patterson AFB, Ohio. The requirement is not set aside for small business concerns and falls under NAICS code 621991. The BPA has a master dollar limit of 425,000 dollars with a call limit of 85,000 dollars per order. The anticipated period of performance runs from December 4, 2026, through October 5, 2031, with deliverables required within 10 days after receipt of order. Award will be made based on the Lowest Price Technically Acceptable (LPTA) basis to the offeror who meets the technical capability requirements and provides the lowest fair and reasonable evaluated price. Mandatory requirements for submission include current SAM registration, a CMMC Level 1 certification recorded in the Supplier Performance Risk System, and the completion of a Required Information Sheet. Quotes must be submitted electronically to the designated contract specialists by October 29, 2026, at 4:00 PM EST. Shipping and acceptance are designated as FOB Destination.

POSTED

DEADLINE

Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.

Solicitation # 0012468284

The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.

POSTED

DEADLINE

Cadaver Medical Training SupportThe Cadaver Medical Training Support subcontract, issued by the Department of Defense under W40M MRC0 West, involves providing technical and logistical assistance to prime contractors for medical training projects. The scope of work focuses on operational support for training days, specifically the preparation and management of cadavers utilizing specialized medical training lab equipment. The contract specifies a delivery requirement of 10 units of support and 10 training days per year. To ensure installation access, personnel are required to complete Anti-Terrorism Level I and iWatch training. This opportunity falls under NAICS code 621991 and is performed in the 78234 zip code area. Interested parties should note the response deadline of October 30, 2026.

POSTED

DEADLINE

6505--Human Blood and Blood Products

Solicitation # 36C25727Q0049

The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Solicitation # RFA-CA-28-004

The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.

National Institutes Of Health

POSTED

DEADLINE

Solicitation # RFA-CA-28-004

The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.

National Cancer Institute

POSTED

DEADLINE

Kidney Transplant Exemption

Solicitation # 2139277

SUNY Downstate Health Sciences University has issued a notice for a single source exemption under solicitation number 2139277 to support its Kidney Transplant Program. This procurement action, which was posted on September 22, 2026, follows the approval of a CRER request by the Office of the State Comptroller on September 18, 2026. The scope of the procurement is specifically tied to the Kidney Transplant Unit having received a kidney for its program. The performance for this action is located at 450 Clarkson Avenue, Brooklyn, New York. As this is a notice of a procurement exempt from advertising, there are no competitive evaluation factors, listed contract terms, or specified contract values. The primary point of contact for this action is Purchase Associate Joanne Fraser.

State University of New York (SUNY)

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)The National Institutes of Health is seeking a Tissue Procurement Center to support the Somatic Mosaicism across Human Tissues (SMaHT) Network. The primary goal of this initiative is to advance the understanding of biological processes and disease mechanisms driven by somatic mutations in human tissues. The center will be responsible for the collection, processing, storage, and distribution of high-quality human tissue specimens to enable functional analyses and the characterization of somatic mosaicism. The program aims to expand its existing foundation of 150 healthy donors by procuring tissues from at least 50 additional healthy individuals, reaching a total of 200. Additionally, the center will collect up to 10 special tissue cohorts, which may include clinically relevant samples, tissues suitable for culture, or organs requiring specialized handling. The awardee will collaborate with other SMaHT Stage 2 initiatives to ensure that all samples are sufficient for production-level assays.

National Institutes Of Health

POSTED

DEADLINE

Blood SamplesThe Department of Commerce is seeking to procure healthy GMP-grade Leukopaks and fresh healthy whole blood samples. These biological materials will be utilized for forensic DNA testing, the production of standard reference materials, the execution of inter-laboratory studies, and the publication of allele frequencies. This requirement is listed as a forecast with the place of performance located in Gaithersburg. The procurement falls under NAICS code 621991, and interested parties may coordinate with the designated point of contact, Daniel Dender, or the Office of Small and Disadvantaged Business Utilization.

POSTED

DEADLINE

Inpatient and Off-Site Facility CoordinationThis subcontract, titled Inpatient and Off-Site Facility Coordination, is issued by the Department of Justice under the agency Fao. The primary scope of work involves the arrangement and monitoring of off-site hospitalizations, diagnostic procedures, and specialty inpatient care, with a specific focus on managing the associated transport logistics. The contract is categorized under NAICS code 621991 and is designated for performance in Pine Knot, Kentucky, 42635. It was posted on August 14, 2026, and is available for further review through the official government workspace link.

POSTED

DEADLINE

Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.

HOUSTON-GALVESTON AREA COUNCIL

POSTED

3 months ago

DEADLINE

in 9 months

General Info

Agency

Department Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

NAICS

621991 - Blood and Organ Banks

Place of Performance

Department of Veterans Affairs VA North Texas Healthcare System Laboratory 4500 S. Lancaster Rd., Dallas, TX, 75216, USA

Set-Aside

NONE

Documents

36C25722Q0221_1.docx

RFQ+36C25722Q0221.pdf

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

Response DeadlineDec 3

Deadline has passed

PostedJan 20

Combined Synopsis

Submission Closed

12/03/2021, 08:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

Contacts1 person available

OfficeSan Antonio, TX, 78240, USA

Organization / AgencyDepartment Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

Office AddressSan Antonio, TX, 78240, USA

Contacts

Delphia SchoenfeldContract Specialist

contact@example.gov

+1 (555) 000-0000

Full Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number 36C25722Q0049 is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2021-07. The NAICS Code for this request for quotes is 621991 ($35.0 million). No set-aside is used for this solicitation. The items being requested are as follows: ITEM NUMBER DESCRIPTION OF SUPPLIES/ SERVICES QUANTITY UNIT 0001 Red Cells, Leukocyte reduced (LRBC) HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 0.00 UN 0001AA Red Cells, LRBC - O+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 1,560.00 UN 0001AB Red Cells, LRBC - O- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 520.00 UN 0001AC Red Cells, LRBC - A+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 1,560.00 UN 0001AD Red Cells, LRBC - A- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 520.00 UN 0001AE Red Cells, LRBC - B+ Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 520.00 UN 0001AF Red Cells, LRBC - B- Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 1 POP Begin: 03-01-2022 POP End: 02-28-2023 260.00 UN 0001AG Red Cells, LRBC - AB+ Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 0.00 UN 0002 Platelets, Pheresis, Leukocyte reduced (LPPLT) HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 0.00 UN 0002AA Platelets, Pheresis, Leukocyte reduced (LPPLT) O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 312.00 UN 0002AB Platelets, Pheresis, Leukocyte reduced (LPPLT) A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 208.00 UN 0003 Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 350.00 UN 0004 Cryoprecipitate, frozen pooled from 5 donors (PCRYO) HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 150.00 UN 0005 Platelet-pheresis, HLA matched HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 UN 0006 Deglycerolyzed Red cells HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 UN 0007 HLA Computer match fee CPT: 86828 Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 10.00 UN 0008 Freezing of Patient RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 EA 0009 Deglycerolization of frozen RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 EA 0010 Directed Donor Fee CPT: NA Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 EA 0011 Autologous Donor Fee CPT: 86890 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 EA 0012 Irradiation Fee CPT: 86945 Estimated Annual Qty: 700 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 700.00 EA 0013 Platelet Crossmatch CPT: 86023 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 EA 0014 Platelet Antibody Screen CPT: 86022 Estimated Annual Qty: 3 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 3.00 EA 0015 Red Blood Cells Washed CPT: NA Estimated Annual Qty: 3 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 3.00 EA 0016 Antigen Screen, Tier 1 antigen (C, c, E, or K) CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 30.00 EA 0017 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 50.00 EA 0018 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 50.00 EA 0019 ABO/Rh type CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 10.00 EA 0020 CMV/ Sickle Screen CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 5.00 EA 0021 Antibody Workup CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 10.00 EA 0022 Frozen Blood Storage (up to 90 days) CPT Code: NA Estimated Annual Qty: 3 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 3.00 EA 0023 Imported Rare Unit Fee CPT Code: NA Estimated Annual Qty: 4 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 4.00 EA 0024 Molecular Phenotyping CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 10.00 EA 0025 Therapeutic Phlebotomy Donation CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 70.00 EA 0026 Therapeutic Phlebotomy Donation (eligible for recipients) CPT Code: NA Estimated Annual Qty: 60 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023 60.00 EA 1001 Red Cells, Leukocyte reduced (LRBC) HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 0.00 UN 1001AA Red Cells, LRBC - O+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 1,560.00 UN 1001AB Red Cells, LRBC - O- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 520.00 UN 1001AC Red Cells, LRBC - A+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 1,560.00 UN 1001AD Red Cells, LRBC - A- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 520.00 UN 1001AE Red Cells, LRBC - B+ Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 520.00 UN 1001AF Red Cells, LRBC - B- Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 260.00 UN 1001AG Red Cells, LRBC - AB+ Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 0.00 UN 1002 Platelets, Pheresis, Leukocyte reduced (LPPLT) HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 0.00 UN 1002AA Platelets, Pheresis, Leukocyte reduced (LPPLT) O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 312.00 UN 1002AB Platelets, Pheresis, Leukocyte reduced (LPPLT) A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 208.00 UN 1003 Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 350.00 UN 1004 Cryoprecipitate, frozen pooled from 5 donors (PCRYO) HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 150.00 UN 1005 Platelet-pheresis, HLA matched HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 UN 1006 Deglycerolyzed Red cells HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 UN 1007 HLA Computer match fee CPT: 86828 Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 10.00 UN 1008 Freezing of Patient RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 EA 1009 Deglycerolization of frozen RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 EA 1010 Directed Donor Fee CPT: NA Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 EA 1011 Autologous Donor Fee CPT: 86890 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 EA 1012 Irradiation Fee CPT: 86945 Estimated Annual Qty: 700 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 700.00 EA 1013 Platelet Crossmatch CPT: 86023 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 EA 1014 Platelet Antibody Screen CPT: 86022 Estimated Annual Qty: 3 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 3.00 EA 1015 Red Blood Cells Washed CPT: NA Estimated Annual Qty: 3 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 3.00 EA 1016 Antigen Screen, Tier 1 antigen (C, c, E, or K) CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 30.00 EA 1017 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 50.00 EA 1018 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 50.00 EA 1019 ABO/Rh type CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 10.00 EA 1020 CMV/ Sickle Screen CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 5.00 EA 1021 Antibody Workup CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 10.00 EA 1022 Frozen Blood Storage (up to 90 days) CPT Code: NA Estimated Annual Qty: 3 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 3.00 EA 1023 Imported Rare Unit Fee CPT Code: NA Estimated Annual Qty: 4 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 4.00 EA 1024 Molecular Phenotyping CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 10.00 EA 1025 Therapeutic Phlebotomy Donation CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 70.00 EA 1026 Therapeutic Phlebotomy Donation (eligible for recipients) CPT Code: NA Estimated Annual Qty: 60 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024 60.00 EA 2001 Red Cells, Leukocyte reduced (LRBC) HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 0.00 UN 2001AA Red Cells, LRBC - O+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 1,560.00 UN 2001AB Red Cells, LRBC - O- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 520.00 UN 2001AC Red Cells, LRBC - A+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 1,560.00 UN 2001AD Red Cells, LRBC - A- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 520.00 UN 2001AE Red Cells, LRBC - B+ Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 520.00 UN 2001AF Red Cells, LRBC - B- Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 260.00 UN 2001AG Red Cells, LRBC - AB+ Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 0.00 UN 2002 Platelets, Pheresis, Leukocyte reduced (LPPLT) HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 0.00 UN 2002AA Platelets, Pheresis, Leukocyte reduced (LPPLT) O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 312.00 UN 2002AB Platelets, Pheresis, Leukocyte reduced (LPPLT) A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 208.00 UN 2003 Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 350.00 UN 2004 Cryoprecipitate, frozen pooled from 5 donors (PCRYO) HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 150.00 UN 2005 Platelet-pheresis, HLA matched HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 UN 2006 Deglycerolyzed Red cells HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 UN 2007 HLA Computer match fee CPT: 86828 Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 10.00 UN 2008 Freezing of Patient RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 EA 2009 Deglycerolization of frozen RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 EA 2010 Directed Donor Fee CPT: NA Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 EA 2011 Autologous Donor Fee CPT: 86890 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 EA 2012 Irradiation Fee CPT: 86945 Estimated Annual Qty: 700 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 700.00 EA 2013 Platelet Crossmatch CPT: 86023 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 EA 2014 Platelet Antibody Screen CPT: 86022 Estimated Annual Qty: 3 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 3.00 EA 2015 Red Blood Cells Washed CPT: NA Estimated Annual Qty: 3 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 3.00 EA 2016 Antigen Screen, Tier 1 antigen (C, c, E, or K) CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 30.00 EA 2017 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 50.00 EA 2018 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 50.00 EA 2019 ABO/Rh type CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 10.00 EA 2020 CMV/ Sickle Screen CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 5.00 EA 2021 Antibody Workup CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 10.00 EA 2022 Frozen Blood Storage (up to 90 days) CPT Code: NA Estimated Annual Qty: 3 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 3.00 EA 2023 Imported Rare Unit Fee CPT Code: NA Estimated Annual Qty: 4 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 4.00 EA 2024 Molecular Phenotyping CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 10.00 EA 2025 Therapeutic Phlebotomy Donation CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 70.00 EA 2026 Therapeutic Phlebotomy Donation (eligible for recipients) CPT Code: NA Estimated Annual Qty: 60 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025 60.00 EA 3001 Red Cells, Leukocyte reduced (LRBC) HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 0.00 UN 3001AA Red Cells, LRBC - O+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 1,560.00 UN 3001AB Red Cells, LRBC - O- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 520.00 UN 3001AC Red Cells, LRBC - A+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 1,560.00 UN 3001AD Red Cells, LRBC - A- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 520.00 UN 3001AE Red Cells, LRBC - B+ Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 520.00 UN 3001AF Red Cells, LRBC - B- Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 260.00 UN 3001AG Red Cells, LRBC - AB+ Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 0.00 UN 3002 Platelets, Pheresis, Leukocyte reduced (LPPLT) HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 0.00 UN 3002AA Platelets, Pheresis, Leukocyte reduced (LPPLT) O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 312.00 UN 3002AB Platelets, Pheresis, Leukocyte reduced (LPPLT) A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 208.00 UN 3003 Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 350.00 UN 3004 Cryoprecipitate, frozen pooled from 5 donors (PCRYO) HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 150.00 UN 3005 Platelet-pheresis, HLA matched HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 UN 3006 Deglycerolyzed Red cells HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 UN 3007 HLA Computer match fee CPT: 86828 Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 10.00 UN 3008 Freezing of Patient RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 EA 3009 Deglycerolization of frozen RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 EA 3010 Directed Donor Fee CPT: NA Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 EA 3011 Autologous Donor Fee CPT: 86890 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 EA 3012 Irradiation Fee CPT: 86945 Estimated Annual Qty: 700 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 700.00 EA 3013 Platelet Crossmatch CPT: 86023 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 EA 3014 Platelet Antibody Screen CPT: 86022 Estimated Annual Qty: 3 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 3.00 EA 3015 Red Blood Cells Washed CPT: NA Estimated Annual Qty: 3 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 3.00 EA 3016 Antigen Screen, Tier 1 antigen (C, c, E, or K) CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 30.00 EA 3017 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 50.00 EA 3018 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 50.00 EA 3019 ABO/Rh type CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 10.00 EA 3020 CMV/ Sickle Screen CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 5.00 EA 3021 Antibody Workup CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 10.00 EA 3022 Frozen Blood Storage (up to 90 days) CPT Code: NA Estimated Annual Qty: 3 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 3.00 EA 3023 Imported Rare Unit Fee CPT Code: NA Estimated Annual Qty: 4 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 4.00 EA 3024 Molecular Phenotyping CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 10.00 EA 3025 Therapeutic Phlebotomy Donation CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 70.00 EA 3026 Therapeutic Phlebotomy Donation (eligible for recipients) CPT Code: NA Estimated Annual Qty: 60 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026 60.00 EA 4001 Red Cells, Leukocyte reduced (LRBC) HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 0.00 UN 4001AA Red Cells, LRBC - O+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 1,560.00 UN 4001AB Red Cells, LRBC - O- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 520.00 UN 4001AC Red Cells, LRBC - A+ Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 1,560.00 UN 4001AD Red Cells, LRBC - A- Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 520.00 UN 4001AE Red Cells, LRBC - B+ Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 520.00 UN 4001AF Red Cells, LRBC - B- Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 260.00 UN 4001AG Red Cells, LRBC - AB+ Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 0.00 UN 4002 Platelets, Pheresis, Leukocyte reduced (LPPLT) HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 0.00 UN 4002AA Platelets, Pheresis, Leukocyte reduced (LPPLT) O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 312.00 UN 4002AB Platelets, Pheresis, Leukocyte reduced (LPPLT) A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 208.00 UN 4003 Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 350.00 UN 4004 Cryoprecipitate, frozen pooled from 5 donors (PCRYO) HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 150.00 UN 4005 Platelet-pheresis, HLA matched HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 UN 4006 Deglycerolyzed Red cells HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 UN 4007 HLA Computer match fee CPT: 86828 Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 10.00 UN 4008 Freezing of Patient RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 EA 4009 Deglycerolization of frozen RBC CPT: NA Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 EA 4010 Directed Donor Fee CPT: NA Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 EA 4011 Autologous Donor Fee CPT: 86890 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 EA 4012 Irradiation Fee CPT: 86945 Estimated Annual Qty: 700 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 700.00 EA 4013 Platelet Crossmatch CPT: 86023 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 EA 4014 Platelet Antibody Screen CPT: 86022 Estimated Annual Qty: 3 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 3.00 EA 4015 Red Blood Cells Washed CPT: NA Estimated Annual Qty: 3 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 3.00 EA 4016 Antigen Screen, Tier 1 antigen (C, c, E, or K) CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 30.00 EA 4017 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 50.00 EA 4018 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 50.00 EA 4019 ABO/Rh type CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 10.00 EA 4020 CMV/ Sickle Screen CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 5.00 EA 4021 Antibody Workup CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 10.00 EA 4022 Frozen Blood Storage (up to 90 days) CPT Code: NA Estimated Annual Qty: 3 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 3.00 EA 4023 Imported Rare Unit Fee CPT Code: NA Estimated Annual Qty: 4 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 4.00 EA 4024 Molecular Phenotyping CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 10.00 EA 4025 Therapeutic Phlebotomy Donation CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 70.00 EA 4026 Therapeutic Phlebotomy Donation (eligible for recipients) CPT Code: NA Estimated Annual Qty: 60 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027 60.00 EA The services being requested are for the reference laboratory testing of patient specimen. Services are to be performed at the VA North Texas Healthcare System, Laboratory, 4500 S. Lancaster Rd., Dallas, TX 75216. The provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition. The provision at 52.212-2, Evaluation-Commercial Items, applies to this acquisition. The evaluation criteria are technical acceptability, past performance, price. Under technical includes the ability to provide all of the requested items in accordance with the Statement of Work, provide a letter of authorization (if not the manufacturer) and a description of equal items, and have, at minimum, a Satisfactory past performance rating. Offerors are to provide a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. The clause at 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. There are no addenda to this clause. The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. The following clauses cited in this clause are applicable: FAR 52.203-6 Restrictions on Subcontractor Sales to the Government (JUN 2020), with Alternate I (OCT 1995) FAR 52.203-13 Contractor Code of Business Ethics and Conduct (JUN 2020) FAR 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017) FAR 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards (JUN 2020) FAR 52.204 23 Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (JUL 2018) FAR 52.204 25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (AUG 2019) FAR 52.209-6 Protecting the Government s Interest when Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment (JUN 2020) FAR 52.209-9 Updates of Publicly Available Information Regarding Responsibility Matters (OCT 2018) FAR 52.209-10 Prohibition on Contracting with Inverted Domestic Corporations (NOV 2015) FAR 52.219-8 Utilization of Small Business Concerns (OCT 2018) FAR 52.219-9 Small Business Subcontracting Plan (JUN 2020) FAR 52.219-28 Post Award Small Business Program Rerepresentation (NOV 2020) FAR 52.222-3 Convict Labor (JUN 2003) FAR 52.222-21 Prohibition of Segregated Facilities (APR 2015) FAR 52.222 26 Equal Opportunity (SEP 2016) FAR 52.222-35 Equal Opportunity for Veterans (JUN 2020) FAR 52.222-36 Equal Opportunity for Workers with Disabilities (JUN 2020) FAR 52.222-37 Employment Reports on Veterans (JUN 2020) FAR 52.222-50 Combating Trafficking in Persons (JAN 2019) FAR 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving (JUN 2020) FAR 52.225-5 Trade Agreements (JUL 2020) Deviation FAR 52.225-13 Restrictions on Certain Foreign Purchases (JUN 2008) FAR 52.229-12 Tax on Certain Foreign Procurements (JUN 2020) FAR 52.232-33 Payment by Electronic Funds Transfer System for Award Management (Oct 2018) FAR 52.242-5 Payments to Small Business Contractors (JAN 2017) Additional Terms and Conditions: FAR 52.203-17 Contractor Employee Whistleblower Rights and Requirement to Inform Employees of Whistleblower Rights (JUN 2020) Far 52.204-4 Printed or Copied Double-Sided on Post-Consumer Fiber Content Paper (MAY 2011) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) FAR 52.204-18 Commercial and Government Entity Code Maintenance (JUL 2016) FAR 52.216-18 Ordering (AUG 2020) FAR 52.216-19 Order Limitations (OCT 1995) FAR 52.216-22 Indefinite Quantity (OCT 1995) FAR 52.217-8 Option to Extend Services (NOV 1999) FAR 52.223-99 Ensuring Adequate COVID-19 Safety Protocols for Federal Contractors (OCT 2021) (Deviation) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (DEC 2013) FAR 52.317-3 Continuity of Services (JAN 1991) VAAR 852.212-70 Provisions and Clauses Applicable to VA Acquisition of Commercial Items (APR 2020) VAAR 852.203 70 Commercial Advertising VAAR 852.219-9 VA Small Business Subcontracting Plan Minimum Requirements VAAR 852.232 72 Electronic Submission of Payment Requests VAAR 852.233-70 Protest Content/ Alternative Dispute Resolution VAAR 852.233-71 Alternate Protest Procedure VAAR 852.246-71 Rejected Goods VAAR 852.246-73 Noncompliance with Packaging, Packing, and/or Marking Requirements VAAR 852.270 1 Representatives of Contracting Officers VAAR 852.273 70 Late Offers VAAR 852.212-71 Gray Market Items VAAR 852.219-71 VA Mentor-Protégé Program (DEC 2009) VAAR 852.219-72 Evaluation Factor for Participation in the VA Mentor-Protégé Program (DEC 2009) VAAR 852.219-75 Subcontracting Commitments Monitoring and Compliance (JUL 2018) VAAR 852.219-76 Subcontracting Plans Monitoring and Compliance (JUL 2018) VAAR 852.242-71 Administrative Contracting Officer (OCT 2020) VAAR 852.247-73 Packing for Domestic Shipment (OCT 2018) Additional Provisions: FAR 52.204-7 System for Award Management (OCT 2018) FAR 52.204-16 Commercial and Government Entity Code Reporting (AUG 2020) FAR 52.204-24 Representation Regarding Telecommunications and Video Surveillance Services or Equipment (AUG 2019) FA...